What are the tumor markers for nasopharyngeal carcinoma?

For nasopharyngeal carcinoma, tumor marker tests may include Epstein-Barr virus-related DNA and antibody tests. Nasopharyngeal carcinoma is a malignant tumor that occurs in the nasopharynx and is often closely related to Epstein-Barr virus infection. By detecting the Epstein-Barr virus DNA load and the corresponding antibody level in the blood, a reference can be provided for the diagnosis, monitoring and prognosis of nasopharyngeal carcinoma.

Common symptoms of NPC include nasal congestion, tinnitus, swollen lymph nodes in the neck, and hearing loss. Tumor marker testing is mainly used to assist in diagnosis and observe the progression of the disease. For example, high levels of EA-IgA and VCA-IgA antibodies may indicate the presence of the disease or an increased risk of recurrence. Quantitative testing of EB virus DNA can be used to evaluate treatment efficacy and monitor the disease.

Common symptoms of NPC include nasal congestion, tinnitus, swollen lymph nodes in the neck, and hearing loss. Tumor marker testing is mainly used to assist in diagnosis and observe the progression of the disease. For example, high levels of EA-IgA and VCA-IgA antibodies may indicate the presence of the disease or an increased risk of recurrence. Quantitative testing of EB virus DNA can be used to evaluate treatment efficacy and monitor the disease.

When conducting such tests, regular checkups and follow-ups are recommended to keep track of the disease. At the same time, maintaining good living habits, increasing exercise and eating a healthy diet can help improve immunity. If you have related symptoms or a family history of the disease, you should see a doctor as soon as possible for a comprehensive evaluation and diagnosis.